ES2969815T3 - Uso de ligandos de receptor sigma en cáncer - Google Patents
Uso de ligandos de receptor sigma en cáncer Download PDFInfo
- Publication number
- ES2969815T3 ES2969815T3 ES17726968T ES17726968T ES2969815T3 ES 2969815 T3 ES2969815 T3 ES 2969815T3 ES 17726968 T ES17726968 T ES 17726968T ES 17726968 T ES17726968 T ES 17726968T ES 2969815 T3 ES2969815 T3 ES 2969815T3
- Authority
- ES
- Spain
- Prior art keywords
- yloxy
- methyl
- compound
- ethyl
- pyrazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382258 | 2016-06-06 | ||
| PCT/EP2017/063614 WO2017211763A1 (en) | 2016-06-06 | 2017-06-05 | Use of sigma receptor ligands in cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2969815T3 true ES2969815T3 (es) | 2024-05-22 |
Family
ID=56134287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17726968T Active ES2969815T3 (es) | 2016-06-06 | 2017-06-05 | Uso de ligandos de receptor sigma en cáncer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190142840A1 (enExample) |
| EP (1) | EP3463339B1 (enExample) |
| JP (1) | JP7094231B2 (enExample) |
| CN (1) | CN109310672B (enExample) |
| AR (1) | AR108682A1 (enExample) |
| ES (1) | ES2969815T3 (enExample) |
| TW (1) | TW201808300A (enExample) |
| WO (1) | WO2017211763A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019387370A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006021462A1 (en) * | 2004-08-27 | 2006-03-02 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
| GB0907973D0 (en) | 2009-05-08 | 2009-06-24 | Modern Biosciences Plc | Combination therapy |
| EP2292236A1 (en) * | 2009-08-14 | 2011-03-09 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| WO2011064315A1 (en) | 2009-11-25 | 2011-06-03 | Laboratorios Del Dr. Esteve, S.A. | 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts |
| SI2531177T1 (sl) | 2010-02-04 | 2016-10-28 | Laboratorios Del Dr. Esteve, S.A. | 4-(2-((5-metil-1(2-naftalenil)-1h-pirazol-3-il)oksi)etil)morpholin hidroklorid polimorfi in solvati |
| EP2388005A1 (en) * | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
-
2017
- 2017-06-05 US US16/306,946 patent/US20190142840A1/en not_active Abandoned
- 2017-06-05 ES ES17726968T patent/ES2969815T3/es active Active
- 2017-06-05 JP JP2018564983A patent/JP7094231B2/ja active Active
- 2017-06-05 AR ARP170101529A patent/AR108682A1/es unknown
- 2017-06-05 EP EP17726968.5A patent/EP3463339B1/en active Active
- 2017-06-05 TW TW106118544A patent/TW201808300A/zh unknown
- 2017-06-05 CN CN201780034885.9A patent/CN109310672B/zh active Active
- 2017-06-05 WO PCT/EP2017/063614 patent/WO2017211763A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3463339C0 (en) | 2023-12-06 |
| WO2017211763A1 (en) | 2017-12-14 |
| US20190142840A1 (en) | 2019-05-16 |
| CN109310672A (zh) | 2019-02-05 |
| CN109310672B (zh) | 2022-05-03 |
| TW201808300A (zh) | 2018-03-16 |
| JP7094231B2 (ja) | 2022-07-01 |
| EP3463339A1 (en) | 2019-04-10 |
| JP2019517572A (ja) | 2019-06-24 |
| AR108682A1 (es) | 2018-09-12 |
| EP3463339B1 (en) | 2023-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110772639B (zh) | Bcl-2抑制剂与MDM2抑制剂的组合产品及其在预防和/或治疗疾病中的用途 | |
| ES2909612T3 (es) | Compuestos de aminotiazol y uso de los mismos | |
| ES2576497T3 (es) | Compuesto de piperidina novedoso o sal del mismo | |
| MX2007008809A (es) | Combinaciones de inhibidores de pirazol cinasa y otros agentes antitumor. | |
| AU2013341271A1 (en) | Combination therapy | |
| KR20170125951A (ko) | 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드 | |
| KR20180013851A (ko) | 치환된 2,3-디히드로이미다조[1,2-c]퀴나졸린-함유 조합물 | |
| TW202019409A (zh) | Bcl-2抑制劑與利妥昔單抗和/或苯達莫司汀或bcl-2抑制劑與chop聯合用藥的協同抗腫瘤作用 | |
| CA3189632A1 (en) | Combination therapy | |
| CN106474127A (zh) | 用于治疗增生性疾病的2‑甲酰胺环氨基尿素衍生物与Hsp90抑制剂的组合 | |
| US20240245704A1 (en) | Pharmaceutical composition and use of multi-kinase inhibitor | |
| US20160128988A1 (en) | Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor | |
| ES2969815T3 (es) | Uso de ligandos de receptor sigma en cáncer | |
| JP6445082B2 (ja) | ５’−ヒドロキシ−５−ニトロ−インジルビン−３’−オキシムを有効成分として含有する乳がん治療剤 | |
| CN108187055B (zh) | 一种具有协同增效作用的抗癌组合物 | |
| WO2015097322A1 (es) | Uso de antagonistas no peptídicos de nk1 en una determinada dosis para el tratamiento del cáncer | |
| ES2701975A2 (es) | Uso de ligandos del receptor sigma en el dolor post-herpetico | |
| WO2019176985A1 (ja) | 抗腫瘍剤、抗腫瘍効果増強剤及び抗腫瘍用キット | |
| HK40065706A (zh) | 一种parp抑制剂tsl-1502中间体tsl-1502m的用途 | |
| HK40065706B (zh) | 一种parp抑制剂tsl-1502中间体tsl-1502m的用途 | |
| JP2024526918A (ja) | 癌の処置におけるｂａｋアクティベーター、医薬組成物および使用 | |
| HK40066075B (zh) | 一种含有tsl-1502m的药物组合物及其应用 | |
| HK40066075A (zh) | 一种含有tsl-1502m的药物组合物及其应用 | |
| HK40021583B (en) | Combination product of bcl-2 inhibitor and mdm2 inhibitor and use thereof in the prevention and/or treatment of diseases | |
| HK40021583A (en) | Combination product of bcl-2 inhibitor and mdm2 inhibitor and use thereof in the prevention and/or treatment of diseases |